{"ticker": {"uuid": "4d9b68dd-fd4b-44bf-87ad-12b59e08e622", "symbol": "T14", "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited", "exchange": "SES", "country": "SG", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Tianjin Pharma\u2019s controlling shareholder ups stake; proposes to further increase stake in six months", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOTTJxM3hnT2hCa2xWNWU2RVVSVGI5OC1wTElnUkFLZVE2aEJmaUt1XzNBLUl3Q05ocUo5X3d0TG5INl9Td0s3a2dZZjZwUDNCeEtxbkZLdE1IeEZ4bnRBdmRMeE5PM2RkUmt5RmhRRFVqdnZUWHNMSGtNRlJJUGE0N3JYRkFCQ3FrRmZhaG4wVXhfWjlOelNrUlVRRGRMbkcwUTE5LXcyZm16LWlGU0hacS0xbm96c0FDZlNBRUEzd2l6Nzc2NFcxVHR3?oc=5", "source_name": "The Edge Singapore", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Full Year Financial Statement and Dividend Announcement \u2013 Minichart", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxPRkpyV0VYRXNCc0ROcE9PLUM3VlVHMFk4aFZtaU8xOGJXTUVLMHJtWVVMSzhBcHBkSFNHTjRzR0djR3VuQUhCekRITzBVSUpWWVdxeWdva1p6T2NhcVB0MUtjNkdQam9xbFEydTU5dHU0ZktMSWlHLWNtaTV3Q21TWlhNTW5LTS1Yc3hITUJvWkhqT2lTZndTZmI4MjZzWlFDNi1zOG5MRkk3U1VpQXRpQ1dMRy1FOTdGdWJjOGt6UFRmb2gycm1vcWk0TXVWUW1KZV9HN1d6RHNvS01CVUFoYTk4ZzNrV1A4bllFdFJn?oc=5", "source_name": "Minichart", "published_at": "2025-03-30T07:00:00+00:00", "published_display": "30 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tianjin Pharmaceutical tops sector; Haw Par and Riverstone named as well", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Edge Singapore", "published_at": "2024-11-12T08:00:00+00:00", "published_display": "12 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Tianjin Pharma\u2019s controlling shareholder ups stake; proposes to further increase stake in six months", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOTTJxM3hnT2hCa2xWNWU2RVVSVGI5OC1wTElnUkFLZVE2aEJmaUt1XzNBLUl3Q05ocUo5X3d0TG5INl9Td0s3a2dZZjZwUDNCeEtxbkZLdE1IeEZ4bnRBdmRMeE5PM2RkUmt5RmhRRFVqdnZUWHNMSGtNRlJJUGE0N3JYRkFCQ3FrRmZhaG4wVXhfWjlOelNrUlVRRGRMbkcwUTE5LXcyZm16LWlGU0hacS0xbm96c0FDZlNBRUEzd2l6Nzc2NFcxVHR3?oc=5", "source_name": "The Edge Singapore", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Full Year Financial Statement and Dividend Announcement \u2013 Minichart", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxPRkpyV0VYRXNCc0ROcE9PLUM3VlVHMFk4aFZtaU8xOGJXTUVLMHJtWVVMSzhBcHBkSFNHTjRzR0djR3VuQUhCekRITzBVSUpWWVdxeWdva1p6T2NhcVB0MUtjNkdQam9xbFEydTU5dHU0ZktMSWlHLWNtaTV3Q21TWlhNTW5LTS1Yc3hITUJvWkhqT2lTZndTZmI4MjZzWlFDNi1zOG5MRkk3U1VpQXRpQ1dMRy1FOTdGdWJjOGt6UFRmb2gycm1vcWk0TXVWUW1KZV9HN1d6RHNvS01CVUFoYTk4ZzNrV1A4bllFdFJn?oc=5", "source_name": "Minichart", "published_at": "2025-03-30T07:00:00+00:00", "published_display": "30 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tianjin Pharmaceutical tops sector; Haw Par and Riverstone named as well", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Edge Singapore", "published_at": "2024-11-12T08:00:00+00:00", "published_display": "12 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 53, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 54, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 3.05, "latest_week": "2026-06-19", "one_week_move": -3.2, "four_week_move": -5.6, "twelve_week_move": -9.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.059251, "market_dynamics_buy_signal": false, "relative_strength": -3.643758, "fair_value_gap": 52.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 58.478, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.2% over one week, -5.6% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "The Edge Singapore", "count": 2}, {"label": "Minichart", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "54/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.2% over one week, -5.6% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Tianjin Pharma\u2019s controlling shareholder ups stake; proposes to further increase stake in six months"}], "updated_at": "2026-06-22T19:32:48.386258+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}